|
|
Trends and Strategies of Biomedical Industry Development |
SU Yue1,LIU Nan2 |
1.China Nation Centre for Biotechnology Development, Beijing 100036, China
2.Tianjin Key Laboratory of Risk Assessment and Control Technology for Environment and Food Safety, Institute of Hygiene and Environment Medicine, Academy of Military Medical Science, Tianjin 300050, China |
|
|
Abstract Nowadays, biomedical industry has been cultivated as a new source of economic growth in many countries, and its development has been accelerated through adopting different policies and measurements by those governments. Encouraged by policies of advantages and the financial support of the government, Chinese biomedical industry is hopeful to bounce back from the economic crisis soon and embrace the period of rapid growth. By the guidance of our government, a strategic alliance of technology innovation of the bio-industry has been establishing, its resources conformity and advantages mutual complementarities have been promoting, and a mass of stronger innovative enterprises have been forming and clustering by vigorous construction of several hi-tech industry parks. They spur the development and technical innovation of national biomedical industry. The development trends and key points should be broken through cooperation among industries, universities and researches; advanced biotechnology; market access policies and high-standard elites construction, etc. By the guidance of market, the government should put forth a series of plans and policies for industry development to accelerate the construction of industrialized bases of biomedical industry, and encourage the biotech enterprises to finance in multi-channels and forms. Some measurements should be taken to deal with the rapid development of biomedical industry in our country, such as establishing the sharing mechanism of biomedical industry resources and public communication platform, the leading enterprises should play the main role and support the merger and acquisition among big enterprises, strengthening the construction of relative rules and regulations and integrating laws of bio-safe and relative intellectual property rights, etc.
|
Received: 22 September 2009
Published: 07 December 2009
|
|
|
|
[1] |
科学技术部社会发展科技司. 生物医药发展战略报告—产业篇. 北京:科学出版社,2009 Social Development Department, Ministry of Science and Technology.Strategy Report of Biomedicine DevelopmentIndustry. Beijing: Science Press, 2009
|
|
|
[2] |
刘燕华,王宏广. 发展医药科技 建造医药强国——中国医药科技与产业竞争力国际比较. 北京:中国医药科技出版社,2007. 38~40 Liu Y H, Wang H G.Developing Science and Technology of Medicine Constitute the Medical Strong ContryScience and Technology of Medicine in China and the International Comparison of Industry Competition. Beijing:Chinese Medical Science and Technology Press, 2007. 38~40
|
|
|
[3] |
李学勇,王宏广. 发展生物技术,引领生物经济. 北京:中国医药科技出版社,2005.14,15 Li X Y, Wang H G.Developing Biotechnology,Leading Bioeconomy.Beijing: Chinese Medical Science and Technology Press, 2005.14~15
|
|
|
[4] |
2007中国生物技术发展报告. 北京:中国农业出版社,2008 Report of Biotechnology Development in China 2007. Beijing: Chinese Agriculture Press, 2008
|
|
|
[5] |
吴光庆. 抗体专利技术的现状与发展趋势.中国知识产权研究会:各行业专利技术现状及发展趋势报告2007~2008. 北京:科学出版社,2008.150~172 Wu G Q.Status in quo and developing trends of antibody patent technology. Chinese Seminar for Intellectual Property Rights: Reports of Status in quo and Developing Trends of Patent Technology in all Industries 2007~2008. Beijing: Science Press, 2008.150~172
|
|
|
[6] |
Kalorama Information. The protein therapeutics market: The science and business of a growing sector. 2006
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|